BP

Basilea Pharmaceutica

Switzerland - Allschwil
Biotechnology
WebsiteLinkedInCareers Page

Focus: Topical

Basilea Pharmaceutica is a life sciences company focused on Topical.

OncologyInfectious DiseasesImmunologyMetabolic DiseasesGastroenterology
Funding Stage
PUBLIC
Open Jobs
1

Pipeline & Clinical Trials

FungiScope - A Global Emerging Fungal Infection Registry
Invasive Fungal Disease
N/A
Fosmanogepix solution for infusion
Invasive Fungal Infections
N/A
Clinical Trials (1)
NCT06433128Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections
N/A
N/A
Clinical Trials (1)
NCT04087876Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations
N/A
Isavuconazole
Healthy Subjects
Phase 1
Phase 1
Clinical Trials (1)
NCT00771719Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia
Phase 1
Phase 1
Phase 1
Clinical Trials (1)
NCT01026740Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers
Phase 1
Phase 1
isavuconazole
Healthy
Phase 1
Phase 1
Phase 1
Phase 1
Clinical Trials (1)
NCT00771524Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone
Phase 1
Phase 1
Phase 1
Microtubule-Targeted Agent BAL101553
Glioblastoma
Phase 1
Clinical Trials (1)
NCT03250299Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Phase 1
Phase 1
Phase 1
Phase 1
isavuconazonium sulfate - intravenous
Hematological Malignancy
Phase 1
Oral Fosmanogepix
Healthy
Phase 1
Clinical Trials (1)
NCT06961708A Study of Fosmanogepix in Healthy Adult Chinese Subjects
Phase 1
Phase 1
APX001 single IV dose
Fungal Infection
Phase 1
Clinical Trials (1)
NCT02957929Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally
Phase 1
[14C]-APX001 Oral Solution
Fungal Infection
Phase 1
Clinical Trials (1)
NCT04804059A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males
Phase 1
Phase 1
Clinical Trials (1)
NCT05491733A Bioequivalence Study of APX001 High-load and Low-load Tablets
Phase 1
Pyridinylmethyl-14C-labeled isavuconazonium sulfate
Pharmacokinetics of 14C-labeled Isavuconazonium Sulfate
Phase 1
Phase 1
Clinical Trials (1)
NCT04314206VNRX-5024 Safety and PK in Healthy Adult Volunteers
Phase 1
Phase 1
Phase 1
Fosmanogepix
Hepatic Impairment
Phase 1
Clinical Trials (1)
NCT05582187A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function.
Phase 1
Phase 1
Clinical Trials (1)
NCT05488678Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function
Phase 1
Ledaborbactam etzadroxil
Healthy Volunteer
Phase 1
Clinical Trials (1)
NCT06733675Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Phase 1
Phase 1
Ceftobiprole medocaril
Bacterial Infections
Phase 1
Clinical Trials (1)
NCT02527681Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics
Phase 1
Phase 1
Phase 1
ledaborbactam etzadroxil
Pharmacokinetics
Phase 1
Clinical Trials (1)
NCT06665555Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age
Phase 1
Phase 1
Phase 1
Phase 1
Clinical Trials (1)
NCT04877379VNRX-7145 Drug-Drug Interaction in Healthy Adult Volunteers
Phase 1
Phase 1
Phase 1
Clinical Trials (1)
NCT04166669A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001
Phase 1
Phase 1
Phase 1
APX001 with Standard of Care anti-fungal agent
Acute Myeloid Leukemia
Phase 1
Clinical Trials (1)
NCT03333005Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia
Phase 1
Phase 1
Clinical Trials (1)
NCT06808646A Study to Assess the Effect of Ceftobiprole on the PK of Pitavastatin and on Plasma Levels of Coproporphyrin
Phase 1
14C-labeled prodrug isavuconazonium sulfate
Pharmacokinetics of 14C-labeled Isavuconazole
Phase 1
Phase 1
Phase 1
Clinical Trials (1)
NCT00965042Effect of Ceftobiprole on Human Intestinal Microflora
Phase 1
Phase 1
APX001 single dose 1
Fungal Infection
Phase 1
Clinical Trials (1)
NCT02956499Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects
Phase 1

Open Jobs (1)

Initiative application

Allschwil
5y ago
Interview Prep Quick Facts
Portfolio: 22 clinical trials
Open Roles: 1 active job

Hiring Trend

Stable
1
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles